US FDA gives green light for WuXi intermediate manufacturing
The US FDA has completed a pre-approval inspection at a Wuxi PharmaTech facility in order for the firm to manufacture a new intermediate for a client.
Archives for October 30, 2013
update
Granules calls for greater Indian regulatory efficiency; EU API demand drove Q2 gains
API, drug intermediates and formulations firm Granules India ended the second quarter of fiscal 2013 with higher revenue and profit thanks to gains made by all three of its units.
Covance reports strong Q3 with signs of early development recovery
Covance produced solid Q3 results as expected by analysts though whether the CRO can fire both early and late stage development cylinders at once remains a question.
update
Novasep to keep supplying Amarin with Vascepa API
Novasep has confirmed it will keep supplying Amarin with omega-3 API as the US FDA withdraws special status afforded to Vascepa trial.
Teva CEO resigns days after denying departure rumors
Teva CEO Jeremy Levin has resigned just days after he denied rumours he would leave and called the speculation "an invention."